SBC
Sbc Medical Group Holdings I
NASDAQ · Health Care
$4.54
+0.02 (+0.44%)
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 218.21M | 196.08M | 204.47M | 208.63M |
| Net Income | 49.51M | 18.01M | 16.26M | 19.19M |
| EPS | — | — | — | — |
| Profit Margin | 22.7% | 9.2% | 8.0% | 9.2% |
| Rev Growth | — | +18.0% | +6.4% | +0.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 7.66M | 196.46M | 197.20M | 186.85M |
| Total Equity | 225.19M | 161.40M | 138.37M | 145.87M |
| D/E Ratio | 0.03 | 1.22 | 1.43 | 1.28 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 82.08M | 25.90M | 26.85M | 24.03M |
| Free Cash Flow | — | 13.43M | 11.81M | 14.26M |